Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 1: Clinical and prognostic STROBE report.

IF 1.9 4区医学 Q2 OTORHINOLARYNGOLOGY

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2025-04-16 DOI:10.1016/j.anorl.2025.04.002

A Derieppe, K Bourget-Aguilar, P Bordure, G Michel

{"title":"Predictive factors for postoperative outcome after endolymphatic sac surgery. Part 1: Clinical and prognostic STROBE report.","authors":"A Derieppe, K Bourget-Aguilar, P Bordure, G Michel","doi":"10.1016/j.anorl.2025.04.002","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate preoperative predictive factors 2years after endolymphatic sac surgery (ESS) in patients with Ménière's disease (MD).Materials and methods: A retrospective single-center study included patients who underwent ESS between 2015 and 2022, with unilateral MD according to the criteria of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) as revised in 2015, and resistant to first-line medical treatment. The main study endpoint was the incidence of postoperative vertigo episodes. Secondary endpoints comprised hearing preservation at 2years and surgical efficacy.Results: Thirty-eight patients were included. Significant vertigo control was achieved in 63% (n=24). No predictive factors were identified for vertigo control or improvement in quality of life. Pure-tone and speech audiometric results were preserved at 2years. Whether the endolymphatic sac was sectioned or not did not significantly impact surgical outcome.Conclusion: No predictive factors for successful ESS emerged. ESS is a conservative second-line surgical treatment, with key indications for bilateral MD or MD in patients with preserved hearing.","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Annals of Otorhinolaryngology-Head and Neck Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.anorl.2025.04.002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To evaluate preoperative predictive factors 2years after endolymphatic sac surgery (ESS) in patients with Ménière's disease (MD).

Materials and methods: A retrospective single-center study included patients who underwent ESS between 2015 and 2022, with unilateral MD according to the criteria of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) as revised in 2015, and resistant to first-line medical treatment. The main study endpoint was the incidence of postoperative vertigo episodes. Secondary endpoints comprised hearing preservation at 2years and surgical efficacy.

Results: Thirty-eight patients were included. Significant vertigo control was achieved in 63% (n=24). No predictive factors were identified for vertigo control or improvement in quality of life. Pure-tone and speech audiometric results were preserved at 2years. Whether the endolymphatic sac was sectioned or not did not significantly impact surgical outcome.

Conclusion: No predictive factors for successful ESS emerged. ESS is a conservative second-line surgical treatment, with key indications for bilateral MD or MD in patients with preserved hearing.

查看原文本刊更多论文

内淋巴囊手术后预后的预测因素。第一部分：临床和预后STROBE报告。

目的：探讨内淋巴囊手术（ESS）后2年msamimni病（MD）患者的术前预测因素。材料和方法：一项回顾性单中心研究纳入了2015年至2022年间接受ESS的患者，根据2015年修订的美国耳鼻喉-头颈外科学会（AAO-HNS）标准，患有单侧MD，对一线药物治疗有抵抗。主要研究终点是术后眩晕发作的发生率。次要终点包括2年听力保存和手术疗效。结果：纳入38例患者。63% （n=24）的眩晕得到显著控制。没有确定眩晕控制或生活质量改善的预测因素。纯音和语音听力测试结果在2岁时保留。内淋巴囊是否切除对手术结果无显著影响。结论：没有预测ESS成功的因素。ESS是一种保守的二线手术治疗，主要指征是双侧MD或听力保留患者的MD。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Annals of Otorhinolaryngology-Head and Neck Diseases OTORHINOLARYNGOLOGY-

CiteScore

3.70

自引率

28.00%

发文量

审稿时长

12 days

期刊介绍： European Annals of Oto-rhino-laryngology, Head and Neck diseases heir of one of the oldest otorhinolaryngology journals in Europe is the official organ of the French Society of Otorhinolaryngology (SFORL) and the the International Francophone Society of Otorhinolaryngology (SIFORL). Today six annual issues provide original peer reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches and review articles giving most up-to-date insights in all areas of otology, laryngology rhinology, head and neck surgery. The European Annals also publish the SFORL guidelines and recommendations.The journal is a unique two-armed publication: the European Annals (ANORL) is an English language well referenced online journal (e-only) whereas the Annales Françaises d’ORL (AFORL), mail-order paper and online edition in French language are aimed at the French-speaking community. French language teams must submit their articles in French to the AFORL site. Federating journal in its field, the European Annals has an Editorial board of experts with international reputation that allow to make an important contribution to communication on new research data and clinical practice by publishing high-quality articles.